About the Authors

Caterina Guinovart

Affiliations Barcelona Centre for International Health Research, Hospital Clínic/IDIBAPS, Universitat de Barcelona, Barcelona, Spain, Centro de Investigação em Saúde da Manhiça, Manhiça, Maputo, Mozambique

John J. Aponte

Affiliations Barcelona Centre for International Health Research, Hospital Clínic/IDIBAPS, Universitat de Barcelona, Barcelona, Spain, Centro de Investigação em Saúde da Manhiça, Manhiça, Maputo, Mozambique

Jahit Sacarlal

Affiliations Centro de Investigação em Saúde da Manhiça, Manhiça, Maputo, Mozambique, Faculdade de Medicina, Universidade Eduardo Mondlane, Maputo, Mozambique

Pedro Aide

Affiliations Centro de Investigação em Saúde da Manhiça, Manhiça, Maputo, Mozambique, Instituto Nacional de Saúde, Maputo, Mozambique

Amanda Leach

Affiliation GlaxoSmithKline Biologicals, Rixensart, Belgium

Quique Bassat

Affiliations Barcelona Centre for International Health Research, Hospital Clínic/IDIBAPS, Universitat de Barcelona, Barcelona, Spain, Centro de Investigação em Saúde da Manhiça, Manhiça, Maputo, Mozambique

Eusébio Macete

Affiliations Centro de Investigação em Saúde da Manhiça, Manhiça, Maputo, Mozambique, Direcçao Nacional de Saúde, Ministério de Saúde, Maputo, Mozambique

Carlota Dobaño

Affiliations Barcelona Centre for International Health Research, Hospital Clínic/IDIBAPS, Universitat de Barcelona, Barcelona, Spain, Centro de Investigação em Saúde da Manhiça, Manhiça, Maputo, Mozambique

Marc Lievens

Affiliation GlaxoSmithKline Biologicals, Rixensart, Belgium

Christian Loucq

Affiliation PATH Malaria Vaccine Initiative, Bethesda, Maryland, United States of America

W. Ripley Ballou

Affiliation GlaxoSmithKline Biologicals, Rixensart, Belgium

Joe Cohen

Affiliation GlaxoSmithKline Biologicals, Rixensart, Belgium

Pedro L. Alonso

palonso@clinic.ub.es

Affiliations Barcelona Centre for International Health Research, Hospital Clínic/IDIBAPS, Universitat de Barcelona, Barcelona, Spain, Centro de Investigação em Saúde da Manhiça, Manhiça, Maputo, Mozambique

Competing Interests

MVI supports the development and testing of a number of malaria vaccines, including some that can be regarded as competitors. AL, ML, WRB* and JC are currently employed by GSK Biologicals or *were employed at the time the study was conducted. AL, WRB and JC hold shares in GlaxoSmithKline. JC and WRB are inventors on patents relating to malaria vaccines. None of the other authors in this paper have declared a conflict of interest.

Author Contributions

Conceived and designed the experiments: CG JJA CD PLA. Performed the experiments: CG JJA JS PA QB EM PLA. Analyzed the data: JJA ML. Wrote the paper: CG CD CL PLA. Contributed to the interpretation of the results and write up of the manuscript: JJA JS AL CL RB JC. Participated in the design and implementation of the original trial: JS AL RB JC.